InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	3.92Cr 3.37Cr 3.16Cr 2.89Cr 5.4Cr 370.27Cr 5.44Cr 37Cr 15Cr 189.22Cr 15Cr 14Cr 609.42Cr	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	3.92Cr 3.37Cr 3.16Cr 2.89Cr 5.4Cr 370.27Cr 5.44Cr 37Cr 15Cr 189.22Cr 15Cr 14Cr 609.42Cr	EV / Sales 2026 *	4x	EV / Sales 2027 *	1.95x
Free-Float	80.03%	Yield 2026 *	-	Yield 2027 *	-

17/08	InspireMD, Inc., Q2 2026 Earnings Call, Aug 17, 2026
15/08	InspireMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
30/07	InspireMD, Inc. Appoints Kathleen Kennedy as Senior Vice President of Global Sales and Marketing	CI
30/07	InspireMD, Inc. Announces Elimination of Shane Gleason as Chief Commercial Officer, Effective July 31, 2026	CI
24/07	InspireMD Receives Nasdaq Minimum Bid Price Warning	MT
03/07	InspireMD, Inc. Announces Resignation of Raymond W. Cohen from Board and Committees, Effective July 1, 2026	CI
29/06	InspireMD, Inc.(NasdaqCM:NSPR) dropped from Russell 3000E Growth Benchmark	CI
29/06	InspireMD, Inc.(NasdaqCM:NSPR) dropped from Russell Microcap Growth Benchmark Index	CI
20/06	InspireMD, Inc. Announces Recalling Action on CGuard Prime Carotid Stent System 135Cm, 10Mmx30mm	CI
20/06	InspireMD, Inc. Announces Recalling Action for CGuard Prime Carotid Stent System 135cm, 10mmx40mm	CI
20/06	Inspiremd Inc Announces Recalling Action on Cguard Prime Carotid Stent System 135cm, 9mx30mm	CI
20/06	InspireMD, Inc. Announces Recalling of Cguard Prime Carotid Stent System 135Cm, 8Mmx30mm	CI
20/06	InspireMD Inc Announces Recalling Action For CGuard Prime Carotid Stent System 135cm, 8mmx40mm	CI

12/23/12	Piper Sandler Initiates InspireMD at Overweight With $3 Price Target	MT
17/23/17	Alliance Global Adjusts Price Target on InspireMD to $4.75 From $5.15, Maintains Buy Rating	MT

03/09	InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference	AQ
17/08	InspireMD Reports Second Quarter 2026 Financial Results	AQ
11/08	InspireMD to Announce Second Quarter 2026 Financial Results	AQ
08/08	InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
31/07	InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing	AQ

Manager	Title	Age	Since
Marvin Slosman CEO	Chief Executive Officer	62	01/01/2020
Michael Lawless DFI	Director of Finance/CFO	58	25/06/2025
Shany Barel CTO	Chief Tech/Sci/R&D Officer	-	-

InspireMD Share Price NYSE

Stocks

Medical Equipment, Supplies & Distribution

Valuation : InspireMD

Latest news : InspireMD

Last Transcript : InspireMD

Analysts' recommendations : InspireMD

Press Releases : InspireMD

Quotes and Performance

Managers and Directors : InspireMD

Medical Devices & Implants

Financials

Company Profile

Director	Title	Age	Since
Paul Stuka CHM	Chairman	71	02/06/2017
Michael Berman BRD	Director/Board Member	68	07/02/2013
Marvin Slosman BRD	Director/Board Member	62	01/01/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INSPIREMD	-3.81%	+32.01%	-	-	3.91Cr
STRYKER CORPORATION	-1.35%	-4.39%	-20.74%	+8.28%	12TCr
SMITH & NEPHEW PLC	-0.99%	-1.91%	-24.26%	-1.17%	1.21TCr
GLAUKOS CORPORATION	+0.46%	-0.86%	+90.91%	+140.82%	1.06TCr
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.67%	-2.75%	-51.34%	-70.90%	416.22Cr
DOUBLE MEDICAL TECHNOLOGY INC.	+0.91%	-9.24%	-24.44%	+36.04%	245.55Cr
INSIGHT LIFETECH CO., LTD.	-0.31%	-5.16%	-	-	197.93Cr
INSPIRE MEDICAL SYSTEMS, INC.	-1.47%	+2.17%	-27.41%	-73.98%	182.34Cr
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.08%	-4.78%	-19.87%	-25.18%	155.66Cr
Average	-0.92%	-3.06%	-11.02%	+1.98%	1.93TCr
Weighted average by Cap.	-1.15%	-3.88%	-14.23%	+13.69%

	2026 *	2027 *
Net sales	97.99L 84.31L 79.12L 72.39L 1.35Cr 93Cr 1.36Cr 9.36Cr 3.65Cr 47Cr 3.68Cr 3.6Cr 152.46Cr	2.01Cr 1.73Cr 1.63Cr 1.49Cr 2.78Cr 190.31Cr 2.8Cr 19Cr 7.49Cr 97Cr 7.56Cr 7.4Cr 313.22Cr
Net income	-	-
Net Debt	-	-